AstraZeneca Comments On Share Price Movement; Says As A Matter Of Policy, We Do Not Comment On Speculative Media Reports Including Those Related To Ongoing Investigations In China. If Requested, We Will Fully Cooperate With The Chinese Authorities. We Con